NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alex P. HamiltonDirector2024-06-26108,426$0.32
$34.70kSell
Alex P. HamiltonDirector2024-06-2516,574$0.31
$5.14kSell

1 of 1

MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan Arango19.35%1,000,000$1.78MInsider
Jacob D. Cohen11.70%605,000$1.08MInsider
Amanda Elizabeth Hammer3.39%175,000$311.50kInsider
Antonios Isaac1.16%60,000$106.80kInsider
Eugene M. Johnston0.74%38,334$68.23kInsider
Kenny Myers0.71%36,667$65.27kInsider
Lorraine Pamela Dalessio0.71%36,667$65.27kInsider
Ackerman Capital Advisors LLC0.67%34,500$61.41kInstitution
Alex P. Hamilton0.55%28,334$50.43kInsider
Virtu Financial LLC0.40%20,501$36.49kInstitution

1 of 2

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX1.77%38.31%Net Selling
KDLY13.92%1.25%Net Buying
HCTI0.10%99.90%
OTRK0.00%100.00%Net Selling
MNDR11.70%0.00%

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 1.77% institutional shareholders, 38.31% Mangoceuticals insiders, and 59.93% retail investors. Jonathan Arango is the largest individual Mangoceuticals shareholder, owning 1.00M shares representing 19.35% of the company. Jonathan Arango's Mangoceuticals shares are currently valued at $1.69M.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.